SPONSOR
Zhejiang University
Total Trials
9
Recruiting
9
Phases
Phase 2, EARLY_Phase 1, Phase 1, Phase 2
Conditions studied: HypoxiaEsophageal CancerGastric Cancer (Diagnosis)Obstructive Sleep Apnea (OSA)ALLBiliary Tract CancerColorectal CarcinomaGastric Cancer, MetastaticPancreatic Adenocarcinoma (Ductal Adenocarcinoma)Multiple Cancer
Zhejiang University is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Hypoxia, Esophageal Cancer, Gastric Cancer (Diagnosis), Obstructive Sleep Apnea (OSA).
The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhejiang University
How many clinical trials has Zhejiang University sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Zhejiang University, of which 9 are actively recruiting participants. These trials cover conditions including Hypoxia, Esophageal Cancer, Gastric Cancer (Diagnosis). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhejiang University research focus on?
Zhejiang University clinical trials span Hypoxia, Esophageal Cancer, Gastric Cancer (Diagnosis), Obstructive Sleep Apnea (OSA), ALL, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhejiang University clinical trial?
To participate in a Zhejiang University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhejiang University trials with current recruitment status updated daily.
Clinical Trials by Zhejiang University
NCT07307560
Recruiting
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Hypoxia
NCT07252336 Phase 2
Recruiting
A Multicenter Study of CAR-T Cells in Primary Ph+All
ALL
NCT06937567 EARLY_Phase 1
Recruiting
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Biliary Tract Cancer
NCT06633341 EARLY_Phase 1
Recruiting
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
T-lymphoblastic Lymphoma
NCT07090291
Recruiting
China Colorectal Cancer Screening Trial 1 (C-Cost1)
Colorectal Cancer
NCT06503497 EARLY_Phase 1
Recruiting
A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer
Pancreatic Cancer Non-resectable
NCT05827835 Phase 1, Phase 2
Recruiting
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
Hematologic Diseases
NCT07175155
Recruiting
Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients
Hypoxemia
NCT05837052 Phase 2
Recruiting
A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC
Unresectable Lung Non-Small Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology